A small molecule agonist of the atypical chemokine receptor 3 (ACKR3) alleviates fibrosis in a preclinical liver but not lung injury model.
Published in 2022 by
Tom Van Loy 
,
Steven De Jonghe,
Karolien Castermans,
Wouter Dheedene,
Matthias Versele,
Patrick Chaltin,
Aernout Luttun,
Dominique Schols
,
Steven De Jonghe,
Karolien Castermans,
Wouter Dheedene,
Matthias Versele,
Patrick Chaltin,
Aernout Luttun,
Dominique Schols
